Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kateryna Fedorov

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancers|May 16, 2023
Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future DirectionsKateryna Fedorov, Abhishek Maiti, Marina Konopleva
Bone Marrow Transplantation|June 7, 2025
Allo-SCT in relapsed CBF-AML: rethinking the remission requirementKateryna Fedorov, Sameer Ramesh Melinkeri, Ram Vasudevan Nampoothiri
Research and Practice in Thrombosis and Haemostasis|September 17, 2021
Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonistsKateryna Fedorov, Swati Goel, Margarita Kushnir, et al.
Current Hematologic Malignancy Reports|December 28, 2025
Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm DevelopmentKateryna Fedorov, Leo Y Luo, Alexander G Bick, et al.
Frontiers in Oncology|June 6, 2024
Case report: Isolated oligometastatic disease of the prostate from a primary lung adenocarcinomaJosette M Kamel, Simran Arjani, Kateryna Fedorov, et al.
Life (Basel, Switzerland)|March 29, 2023
Identifying Neutrophil Extracellular Traps (NETs) in Blood Samples Using Peripheral Smear AutoanalyzersKateryna Fedorov, Mohammad Barouqa, David Yin, et al.
Leukemia & Lymphoma|November 26, 2025
Pacritinib in patients with myelodysplastic/myeloproliferative neoplasmsMichael Zargari, Nanda Nayak, Michael Canonico, et al.
Leukemia & Lymphoma|October 16, 2024
Complete remission in a case of acute undifferentiated leukemia with novel combination therapy of FLAG-IDA and venetoclaxRoma A Kankaria, Jeremy B Jones, Michael Zargari, et al.
Blood Advances|October 8, 2025
Combining drugs that bypass p53 to treat TP53-mutated leukemiasSudipta Biswas, Zeinab Albadry M Zahran, Xiaorong Gu, et al.
American Journal of Hematology|March 9, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid LeukemiaSomedeb Ball, Farrukh T Awan, Ben K Tomlinson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancers|May 16, 2023
Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future DirectionsKateryna Fedorov, Abhishek Maiti, Marina Konopleva
Bone Marrow Transplantation|June 7, 2025
Allo-SCT in relapsed CBF-AML: rethinking the remission requirementKateryna Fedorov, Sameer Ramesh Melinkeri, Ram Vasudevan Nampoothiri
Research and Practice in Thrombosis and Haemostasis|September 17, 2021
Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonistsKateryna Fedorov, Swati Goel, Margarita Kushnir, et al.
Current Hematologic Malignancy Reports|December 28, 2025
Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm DevelopmentKateryna Fedorov, Leo Y Luo, Alexander G Bick, et al.
Frontiers in Oncology|June 6, 2024
Case report: Isolated oligometastatic disease of the prostate from a primary lung adenocarcinomaJosette M Kamel, Simran Arjani, Kateryna Fedorov, et al.
Life (Basel, Switzerland)|March 29, 2023
Identifying Neutrophil Extracellular Traps (NETs) in Blood Samples Using Peripheral Smear AutoanalyzersKateryna Fedorov, Mohammad Barouqa, David Yin, et al.
Leukemia & Lymphoma|November 26, 2025
Pacritinib in patients with myelodysplastic/myeloproliferative neoplasmsMichael Zargari, Nanda Nayak, Michael Canonico, et al.
Leukemia & Lymphoma|October 16, 2024
Complete remission in a case of acute undifferentiated leukemia with novel combination therapy of FLAG-IDA and venetoclaxRoma A Kankaria, Jeremy B Jones, Michael Zargari, et al.
Blood Advances|October 8, 2025
Combining drugs that bypass p53 to treat TP53-mutated leukemiasSudipta Biswas, Zeinab Albadry M Zahran, Xiaorong Gu, et al.
American Journal of Hematology|March 9, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid LeukemiaSomedeb Ball, Farrukh T Awan, Ben K Tomlinson, et al.
Pageof 2